UCB Group: Long-Term Data on Cimzia(R) for Moderate to Severe Crohns Disease to be Highlighted at Upcoming DDW Meeting

ATLANTA, April 29 /PRNewswire/ -- Studies and analyses of the Crohn’s Disease (CD) treatment Cimzia® (certolizumab pegol) demonstrating new data will be exhibited at Digestive Disease Week (DDW) 2010, taking place in New Orleans from May 1-5, 2010.